Reducing medication risk: François Pesty’s plan (part 5)

by time news

2023-10-30 20:46:31

Medication errors, misuse, irrelevance and inefficiency of prescriptions, the Achilles heel is found in the business software of health professionals. My plan to fix it

A column in ten episodes, ten proposals calling on “digital health”, my Citizens’ Bill in ten amendments to the Social Security financing bill for 2024

Fifth episode: propositions n°4 and n°5

Give the doctor visibility on his drug prescribing practices.

Proposal No. 4

Fourth amendment: “The HAS, responsible for developing certification standards for prescription assistance software in towns, hospitals and social and medico-social establishments, will ensure that they cover functionalities and configurable tools allowing prescribers to report their prescribing practices at the scale of their patients.”

Article L. 161-38 of the Social Security Code (ici) is also modified as follows:

5° In II, after the word “dosages”, the following text is inserted: “The HAS, responsible for developing the certification standards for prescription assistance software in towns, hospitals and establishments social and medico-social, will ensure that they cover configurable functionalities and tools allowing prescribers to report their prescribing practices at the scale of their patient base relating to one or a set of pharmaceutical presentation(s), one or a set of pharmaceutical specialty(ies), possibly linked to one or more therapeutic indication(s) validated by the AMM, after extraction of the data archived in their business software.”

Summary presentation:

Private and hospital doctors are completely deprived of tools for evaluating their professional practices (EPP) allowing them to report, at the level of their patients, the evolution of their prescriptions relating to one or a set of presentation(s). pharmaceutical(s), one or a set of pharmaceutical specialty(s), possibly linked to one or more therapeutic indication(s) validated by the AMM, after extraction of the data archived in their business software.

The analysis of data and the study of variations in drug prescription is recommended in the recent report and the English review on overprescription (icihaving been the subject of a publication in the journal Prescriber : ici). It is stipulated that better use of data can make it possible to better understand overprescription and to remedy it more effectively.

Proposal No. 5

Fifth amendment: “Health Insurance will be responsible, in collaboration with the High Authority of Health, for building an information system allowing by departments, by regions, at the national level, to report the evolution of drug prescribing practices and, if necessary, to compare them with that of the individual patients of doctors, who will have access to graphic analyzes and tables of prescription profiles from a dedicated site. A database which deserves to be made open data ‘.”

Article L. 161-38 of the Social Security Code (ici) is also modified as follows:

6° In II, after the word “patients”, the following text is inserted: “Health Insurance will be responsible, in collaboration with the High Authority of Health, for building an information system allowing by departments, by regions, at the national level, to report the evolution of drug prescribing practices and, if necessary, to compare them with that of the individual patient base of doctors, who will have access to graphic analyzes and tables of prescription profiles from a dedicated site. A database that deserves to be made ‘open data’.”

Summary presentation:

Private and hospital doctors do not have benchmarks to situate their prescribing practices in relation to their colleagues. They are also completely deprived of tools for evaluating their professional practices (EPP) allowing them to report, at the level of their patients, the evolution of their prescriptions relating to one or a set of pharmaceutical presentation(s). s), one or a set of pharmaceutical specialty(ies), possibly linked to one or more therapeutic indication(s) validated by the AMM, after extraction of the data archived in their business software.

The analysis of data and the study of variations in drug prescription is recommended in the recent English report on overprescription (icihaving been the subject of a publication in the journal Prescriber : ici). It is stipulated that better use of data can make it possible to better understand overprescription and to remedy it more effectively.

It is proposed, to compensate for this lack of knowledge, to entrust the Health Insurance, in collaboration with the High Authority of Health, with the construction of a national, regional and departmental database, resulting from the SNIIRAMmaking it possible to analyze and compare the evolution of drug prescribing practices.

#Reducing #medication #risk #François #Pestys #plan #part

You may also like

Leave a Comment